ACADEMY OF MANAGED CARE PHARMACY for ACADEMY OF MANAGED CARE PHARMACY
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Communications and correspondence related to suspension of claims under Medicare Part D for a credible allegation of fraud, electronic prescribing, and prior authorization under Medicare Part D contained in HR 6--The Opioid Crisis Response Act of 2018. Meeting with the Centers for Medicare and Medicaid Services regarding the medication therapy management program under Medicare Part D.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARY JO CARDEN | Vice President, Government & Pharmacy Affairs |
Pharmacy PHA
Sent a letter in support of S. 974, the CREATES Act to the full Senate and communicated in regard to the bill. Dissemination of information in support of H.R. 2026 - Pharmaceutical Information Exchange Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARY JO CARDEN New | Vice President, Government & Pharmacy Affairs |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.